A comprehensive comparison of the safety and efficacy of drugs in the treatment of idiopathic pulmonary fibrosis: a network meta-analysis based on randomized controlled trials.

"Declarations Ethics approval and consent to participateThe authors declare that there is no conflict of interests regarding the publication of this paper. Consent for publicationNot applicable. Competing interestsThe authors declare that there is no conflict of interests regarding the publication of this paper. Competing interests The authors declare that there is no conflict of interests regarding the publication of this paper."

"Funding This work is supported by Guizhou Provincial Basic Research Program(Natural Science) (Qiankehe Foundation-ZK[2023]General 411),Academic New Seedling Project of Guizhou University of Traditional Chinese Medicine (Guike Cooperative Academic New Seedling [2023]-22), Innovation and Entrepreneurship Training Program for College Students of Guizhou University of Traditional Chinese Medicine, China (Gui Zhong Yi Da Chuang He Zi (2022) No. 90) ,and Project of Education Department of Guizhou Province, China (Guizhou Education Technology 2022-023)."

"This study has been registered in PROSPERO(https://www.crd.york.ac.uk/prospero/), registration number: CRD42023385689. The procedure of this protocol is based on PRISMA-P guidance []. Methods: The PubMed, EMbase, CENTRAL and MEDLINE were retrieved to find out the RCTs of drugs in the treatment of IPF. The retrieval date is from construction to November 10, 2022. Stata 14.0 and RevMan 5.3 was used for statistical analysis. Registration number: CRD42023385689."